179 related articles for article (PubMed ID: 6243728)
1. Interrelationships among insulin, glucagon, and gastric inhibitory polypeptide in insulinoma.
Nelson RL; Service FJ; Go VL
Mayo Clin Proc; 1980 Mar; 55(3):138-45. PubMed ID: 6243728
[TBL] [Abstract][Full Text] [Related]
2. Glucose-induced GIP levels in patients with insulinoma.
Tamburrano G; Lala A; Mauceri M; Leonetti F; Andreani D
Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
[TBL] [Abstract][Full Text] [Related]
3. The differential effect of intragastric and intravenous tryptophan on plasma glucose, insulin, glucagon, GLI and GIP in the fasted rat.
Tsiolakis D; Marks V
Horm Metab Res; 1984 May; 16(5):226-9. PubMed ID: 6376308
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin.
Rizza RA; Haymond MW; Verdonk CA; Mandarino LJ; Miles JM; Service FJ; Gerich JE
Diabetes; 1981 May; 30(5):377-81. PubMed ID: 6262168
[TBL] [Abstract][Full Text] [Related]
5. Plasma glucagon in insulinoma.
Ohneda A; Matsuda K; Horigome K; Ishii S; Yanbe A; Maruhama Y
Acta Diabetol Lat; 1977; 14(5-6):219-28. PubMed ID: 207064
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas.
Rehfeld JF
Scand J Gastroenterol Suppl; 1979; 53():33-8. PubMed ID: 225784
[TBL] [Abstract][Full Text] [Related]
7. Gastric inhibitory polypeptide, insulin, and glucose changes produced by growth hormone, prednisolone, glucagon, insulin, fasting, or diazoxide.
Williams RH
Proc Soc Exp Biol Med; 1979 Oct; 162(1):157-62. PubMed ID: 504226
[No Abstract] [Full Text] [Related]
8. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of insulin, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion by octreotide has no effect on post-heparin plasma lipoprotein lipase activity.
Ranganath LR; Beety JM; Morgan LM
Horm Metab Res; 1999 Apr; 31(4):262-6. PubMed ID: 10333081
[TBL] [Abstract][Full Text] [Related]
10. Effects of a gastric partitioning operation for morbid obesity on the secretion of gastric inhibitory polypeptide and pancreatic polypeptide.
Amland PF; Jorde R; Kildebo S; Burhol PG; Giercksky KE
Scand J Gastroenterol; 1984 Sep; 19(6):857-61. PubMed ID: 6393318
[TBL] [Abstract][Full Text] [Related]
11. Lack of negative feed-back regulation of insulin on the responses of gastric inhibitory polypeptide, insulin, glucagon and pancreatic polypeptide to a meal in insulin treated diabetics.
Krarup T; Madsbad S; Tronier B
Diabete Metab; 1984 Sep; 10(3):171-4. PubMed ID: 6386555
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal hormones in anorexia nervosa.
Alderdice JT; Dinsmore WW; Buchanan KD; Adams C
J Psychiatr Res; 1985; 19(2-3):207-13. PubMed ID: 3900360
[TBL] [Abstract][Full Text] [Related]
13. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
[TBL] [Abstract][Full Text] [Related]
14. Glucose intolerance in a patient with insulinoma. Report of a case.
Christiansen J; Munkgaard S
Acta Chir Scand; 1974; 140(7):578-80. PubMed ID: 4376322
[No Abstract] [Full Text] [Related]
15. Direct effect of insulin on secretion of insulin, glucagon, gastric inhibitory polypeptide, and gastrin during maintenance of normoglycemia.
Service FJ; Nelson RL; Rubenstein AH; Go VL
J Clin Endocrinol Metab; 1978 Sep; 47(3):488-93. PubMed ID: 400722
[TBL] [Abstract][Full Text] [Related]
16. Study of hypoglycemic patients by the glucose clamp technique using the artificial pancreas.
Pontiroli AE; Secchi A; Dabandi M; Alberetto M; Bosi E; Fantaguzzi S; Pozza G
J Clin Endocrinol Metab; 1983 Dec; 57(6):1297-300. PubMed ID: 6313737
[TBL] [Abstract][Full Text] [Related]
17. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
McDonald TJ; Dupre J; Caussignac Y; Radziuk J; Van Vliet S
Metabolism; 1979 Apr; 28(4):300-7. PubMed ID: 449682
[TBL] [Abstract][Full Text] [Related]
18. Increased gastric inhibitory polypeptide levels in patients with symptomatic postprandial hypoglycemia.
Hadji-Georgopoulos A; Schmidt MI; Elahi D; Hershcopf R; Kowarski AA
J Clin Endocrinol Metab; 1983 Apr; 56(4):648-52. PubMed ID: 6339535
[No Abstract] [Full Text] [Related]
19. The use of glucagon challenge tests in the diagnostic evaluation of hypoglycemia due to hepatoma and insulinoma.
Pun KK; Young RT; Wang C; Tam CF; Ho PW
J Clin Endocrinol Metab; 1988 Sep; 67(3):546-50. PubMed ID: 2842361
[TBL] [Abstract][Full Text] [Related]
20. Lack of diabetogenic action of calcitonin in subjects affected by insulinoma.
Passariello N; Paolisso G; Iannuzzi F; Pizza G; Marrazzo G; Sgambato S; D'Onofrio F
Diabete Metab; 1989; 15(2):88-92. PubMed ID: 2544469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
